Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients

Clinical Nutrition

Volumn 18, Issue 4, 1999, Pages 227-231

  De Luis, D A ^a,b   Avello, A Garcia ^a   Lasuncion, M A ^a   Aller, R ^a   De Argila, C Martin ^a   De Miquel, D Boixeda ^a   De La Calle, H ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE   (Spain)

Author keywords

Haemostasis; Helicobacter pylori; Lipids

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CLARITHROMYCIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEPRAZOLE; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX; TRIACYLGLYCEROL; UREASE;

ADULT; ARTICLE; BREATH ANALYSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTION; HEMOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MALE; SEROLOGY;

EID: 0033405455     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(99)80074-0     Document Type: Article

References (30)

1. Mendall M A, Goggin P M, Mollineaux N. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-439
2. de Luis D A, Lahera M, Canton R et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998; 21: 1129-1132
3. Torgano G, Perondi R, Tien Tu V, Bertinieri G, Pagnozzi G, Valentini P. Changes in plasma fibrinogen levels after eradication of Helicobacter pylori infection in patients affected by coronary heart disease. Gastroenterology 1997; (Suppl 1) 714
4. Mendall M A, Patel P, Ballam L, Strachan D, Northfield T C. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065
5. Scragg R K R, Fraser A, Metcalf P A. Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Commun Heath 1996; 50: 578-579
6. Niemelä S, Karttunen T, Korhonen T, Läärä E, Karttunen R, IkÄheimo M. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?. Heart 1996; 75: 573-575
7. Cabana V G, Siegel J N, Sabesin S M. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J of Lipid Research 1989; 30: 39-4-9
8. Kumon Y, Suehiro T, Ikeda Y, Yoshida K, Hashimoto K, Ohno F. Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease. Clin Biochemistry 1993; 26: 505-511
9. Hiramatsu K, Rosen H, Heinecke J W, Wolbuer G, Chair A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 1977; 7: 55-60
10. Miragliotta G, Del Prete R, Mosca A. Helicobacter pylori infection and coronary heart disease. Lancet 1994; 344: 751
11. Bierti L, Cernuschi C, Abbiati C et al. Correlation between gastric infection with Helicobacter pylori and plasma levels of fibrinogen, plasminogen activator inhibitor (PAI) and von Willebrand factor (vW) antigen. Gastroenterology 1997; A90
12. Blasi F, Denti F, Erba M et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J of Clin Microbiol 1996; 34: 2766-2769
13. Gisbert J P, Boixeda D, Redondo C et al. Breath test in the diagnosis of Helicobacter pylori infection: Concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa. Rev Esp Enf Dig 1996; 88: 259-264
14. Booth L, Holdstock G, MacBride H. Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol 1986; 39: 215-219
15. Von Clauss A. A gerinnungsphysiologische Schellmethode zur Bestimmung des fibrinogens. Acta Haematol 1957; 17: 237-246
16. Declerk P J. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody based enzyme-linked immunosorbant assay. Blood 1988; 71: 220-225
17. Bergsdorf N. An enzyme linked immunoabsorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Haemostas 1983; 50: 740-744
18. Laurell C B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 24 (Supl): 21-26
19. Morgando A, Sanseverino P, Perotto C, Molino F, Gai V, Ponzetto A. Helicobacter pylori seropositivity in miocardial infarctation. Lancet 1995; 345: 1380
20. Crabtree J E, Shallcross T M, Healtley R V, Wyatt J I. Mucosal tumour necrosis factor and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-1477
21. Mendall M A, Patel P, Asante M et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: 273-277
22. Fisher R H, Denniston J C, Beisel W R. Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: Changes in plasma lipids and lipoproteins. J Infect Dis 1972; 125: 54-60
23. Kaufman R L, Matson C F, Rowberg A H. Defective lipid disposal mechanisms during bacterial infection in Rhessus monkeys. Metabolism 1976; 25: 615-624
24. Akerlund B, Carlson L, Jarstrand C. Dyslipoproteinemia in patients with severe bacterial infections. Scand J Infect Dis 1986; 18: 539-545
25. Samalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen M R. Changes in serum lipoproteins pattern induced by acute infections. Metabolism 1988; 37: 859-865
26. Crook A. Elevated Lp(a) levels in patients with endometriosis. Metabolism 1997; 735-739
27. Wade D P, Clarke J G, Lindhal G E. 5'Control regions of the apolipoprotein (a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993; 90: 1369-1373
28. Levi M, Van der Poll T, Ten Gate H, Van Deventer S H J. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J of Clin Investig 1997; 27: 3-9
29. Perri F, Festa V, Clemente R et al. Serum TNF, CagA status, endoscopic and histological findings in Helicobacter pylori infected patients. Gastroenterology International 1998; 11: 129
30. Strachan D P, Mendall M A, Carrignton D et al. Relation of H. pylori infection to 13 year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation 1998; 98: 1286-1290